Literature DB >> 9155523

A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy.

C E Nightingale1, A Norman, D Cunningham, J Young, A Webb, J Filshie.   

Abstract

We present a prospective analysis of the insertion complications and longevity of 949 cuffed, tunnelled central venous catheters used for ambulatory chemotherapy. Mean catheter life span was 121.8 days, 13.4% had complications at insertion, 17.7% had complications not necessitating removal and 18.6% had complications requiring removal. The more experienced operators had fewer complications inserting catheters (P < 0.0001). Late-onset shoulder pain occurred in 4.8% and was associated with an increased incidence of venous thrombosis (P < 0.0001) and infection (P = 0.06). Complications necessitating removal were not predicted by patient' age, site of insertion or malignancy, chemotherapy regimen, insertion platelet and fibrinogen counts, insertion complications, leucocyte count or cuff distance from the exist site. Catheters inserted with their tip in the superior vena cava were more at risk of removal (2.57 times) than those in the right atrium (P = 0.003).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155523     DOI: 10.1016/s0959-8049(97)89012-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

1.  Preferences of patients with advanced colorectal cancer for treatment with oral or intravenous chemotherapy.

Authors:  Candida M Mastroianni; Caterina Viscomi; Silvia Ceniti; Rosanna De Simone; Aldo Filice; Gennaro Gadaleta Caldarola; Stefania Infusino; Caterina Manfredi; Antonio Rea; Claudia Sandomenico; Salvatore Turano; Francesco Serranò; Giovanni Condemi; Carla Cortese; Tullia Prantera; Salvatore Palazzo
Journal:  Patient       Date:  2008-07-01       Impact factor: 3.883

2.  Outcome of cephalic vein cut-down approach: A safe and feasible approach for totally implantable venous access device placement.

Authors:  Shinichiro Koketsu; Shinishi Samesima; Satomi Yoneyama; Toshiyuki Okada; Shigeru Tomozawa; Hiroyuki Horikoshi; Toshio Sawada
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

3.  Ultrasound-guided vein puncture versus surgical cut-down technique in totally implantable venous access devices (TIVADS): a prospective comparative study on safety, efficacy andcomplications.

Authors:  Giuseppe Cavallaro; Alessandro Sanguinetti; Olga Iorio; Giuseppe D'Ermo; Andrea Polistena; Nicola Avenia; Gianfranco Silecchia; Giorgio De Toma
Journal:  Int Surg       Date:  2014 Jul-Aug

4.  Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site.

Authors:  C S Karapetis; D Yip; K Virik; A Strickland; K Ryder; M Cowling; P G Harper
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

5.  Pinch-off syndrome: transection of implantable central venous access device.

Authors:  Takuya Sugimoto; Hiroshi Nagata; Ken Hayashi; Nobuyasu Kano
Journal:  BMJ Case Rep       Date:  2012-11-30

Review 6.  Primary thromboprophylaxis for cancer patients with central venous catheters--a reappraisal of the evidence.

Authors:  M S Cunningham; B White; D Hollywood; J O'Donnell
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

7.  Right or left? Side selection for a totally implantable vascular access device: a randomised observational study.

Authors:  Wen-Ying Lin; Chih-Peng Lin; Chih-Hung Hsu; Ying-Hui Lee; Yi-Ting Lin; Meng-Chi Hsu; Yu-Yun Shao
Journal:  Br J Cancer       Date:  2017-08-08       Impact factor: 7.640

Review 8.  Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature.

Authors:  J Vardy; K Engelhardt; K Cox; J Jacquet; A McDade; M Boyer; P Beale; M Stockler; R Loneragan; B Dennien; R Waugh; S J Clarke
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

9.  External jugular vein cutdown approach for chronic indwelling central venous access in cancer patients: A potentially useful alternative.

Authors:  Stephen P Povoski
Journal:  World J Surg Oncol       Date:  2004-04-16       Impact factor: 2.754

10.  Risk associated with central catheters for malignant tumor patients: a systematic review and meta-analysis.

Authors:  Yajuan Lv; Yong Hou; Bo Pan; Yuwan Ma; Paiyun Li; Lili Yu; Deguo Xu; Juanjuan Song; Heli Shang; Hongyan Wang; Yuan Tian
Journal:  Oncotarget       Date:  2018-01-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.